These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
187 related items for PubMed ID: 18514701
1. Management of gastrointestinal stromal tumors. Hueman MT, Schulick RD. Surg Clin North Am; 2008 Jun; 88(3):599-614, vii. PubMed ID: 18514701 [Abstract] [Full Text] [Related]
2. Gastrointestinal stromal tumors of the stomach. Bennett JJ, Rubino MS. Surg Oncol Clin N Am; 2012 Jan; 21(1):21-33. PubMed ID: 22098829 [Abstract] [Full Text] [Related]
4. Current management of gastrointestinal stromal tumors--a comprehensive review. Lai EC, Lau SH, Lau WY. Int J Surg; 2012 Jan; 10(7):334-40. PubMed ID: 22633986 [Abstract] [Full Text] [Related]
5. The role of KIT in the management of patients with gastrointestinal stromal tumors. Hornick JL, Fletcher CD. Hum Pathol; 2007 May; 38(5):679-87. PubMed ID: 17437861 [Abstract] [Full Text] [Related]
8. [Resistance against tyrosine kinase inhibitors in the treatment of GIST. New therapeutic possibilities appear]. Ahlman H, Nilsson O, Nilsson B. Lakartidningen; 2007 May 19; 106(50-51):3424-9. PubMed ID: 20180446 [No Abstract] [Full Text] [Related]
9. NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors. Demetri GD, von Mehren M, Antonescu CR, DeMatteo RP, Ganjoo KN, Maki RG, Pisters PW, Raut CP, Riedel RF, Schuetze S, Sundar HM, Trent JC, Wayne JD. J Natl Compr Canc Netw; 2010 Apr 19; 8 Suppl 2(0 2):S1-41; quiz S42-4. PubMed ID: 20457867 [Abstract] [Full Text] [Related]
13. Combined treatment strategies in gastrointestinal stromal tumors (GISTs) after imatinib and sunitinib therapy. Pantaleo MA, Nannini M, Di Battista M, Catena F, Biasco G. Cancer Treat Rev; 2010 Feb 19; 36(1):63-8. PubMed ID: 19914780 [Abstract] [Full Text] [Related]
14. Activity of nilotinib (AMN-107) alone in advanced gastrointestinal stromal tumors progressing on imatinib and sunitinib. Case report. Sevinc A. Chemotherapy; 2009 Feb 19; 55(2):132-6. PubMed ID: 19188713 [Abstract] [Full Text] [Related]
17. [Gastrointestinal stromal tumors. An update]. Bórquez Ma P, Neveu C R. Rev Med Chil; 2008 Jul 19; 136(7):921-9. PubMed ID: 18949171 [Abstract] [Full Text] [Related]
18. Imaging of gastrointestinal stromal tumors before and after imatinib mesylate therapy. Shankar S, Dundamadappa SK, Karam AR, Stay RM, van Sonnenberg E. Acta Radiol; 2009 Oct 19; 50(8):837-44. PubMed ID: 19735005 [Abstract] [Full Text] [Related]
19. Improved insight into resistance mechanisms to imatinib in gastrointestinal stromal tumors: a basis for novel approaches and individualization of treatment. Sleijfer S, Wiemer E, Seynaeve C, Verweij J. Oncologist; 2007 Jun 19; 12(6):719-26. PubMed ID: 17602061 [Abstract] [Full Text] [Related]
20. New strategies for treating GIST when imatinib fails. Boyar MS, Taub RN. Cancer Invest; 2007 Aug 19; 25(5):328-35. PubMed ID: 17661208 [Abstract] [Full Text] [Related] Page: [Next] [New Search]